Team:Macquarie Australia/WetLab/Notebook
From 2014.igem.org
The Notebook
Welcome to our Notebook! This page has been created to detail our projects progress since its conception. Click on the section titles below to expand pages that contain information regarding what we worked on and achieved each week. For a more detailed summary of what we achieved please visit the Results page.
November 2013
Week 1
Biobrick stocktake of 2013 iGEM Macquarie_Australia parts: 11/11/13
- ChlG - sufficient plasmid stock
- DVR1 - sufficient plasmid stock
- ChlM - sufficient plasmid stock
- ChlI2 - need more plasmid stock
- POR- need more plasmid stock
- YCF - need more plasmid stock
- Plasto - need more plasmid stock
- GUN4- need more plasmid stock
- CTH1 - need more plasmid stock
- ChlD - need more plasmid stock. Question whether the 2013 part is really the reported sequence - something appears to be missing.
Send all for re-sequencing to verify DNA sequence as per registry entries.
DVR1 re-tranformation: Was re-done using gibson assembly and then transformed.
Week 2
Sequencing Results: all parts except ChlD were correct.ChlD Fix: ChlD is missing 50 bp. Strategy to correct is to use ApaI and MluI restriction enzymes to cut out 50bp from clone of ChlD in pET vector from Willows group and re-insert into our BioBrick vector.
ApaI and MluI were used in a single digest according to manufacturer's instructions and as per ligation protocol on methods wiki. Fragments run on 1% agarose and gel purified. However, digestions were incomplete as viewed on agarose gel. Need to do separate digests for next attempt.
Double restriction enzyme digest was carried out to combine PCR1 and Gblock2. After the two sections were ligated and extended, straight PCR was done. The PCR worked as judged by agarose gel.
Week4
Tuesday: 26/11/13 Composite parts AssemblyBiobrick (BB) ChlI1 is combined with ChlI2 biobrick in AMP backbone. Method is via 3A assembly. Use 500ng of each part and insert into 500ng of amp backbone. Ligation for 16oC for 30 mins then 80oC for 20 mins. Leave plates over weekend at room temperature.
Growth on plates : 1 colony on low plate, hundreds on high plate.
Assembly of ChlH: PCR of individual fragments from ChlH: 29/11/13- G1 - G1F + G1R
- G2 - G2F+ G2R
- G3 - G3F + G4R
- G4 - G4F+ G4R
- G5 - G5F + G5R
- G6 - G6F + G6R
- PCR1+ G2- H1F+ G2R
- (PCR1 + G2) + G1
- G3 + PCR2- G3F+ H2R
- G5 + G6- G5F +G6R
Increase stocks : Did plasmid preps to get more of: ChlI1; ChlI2; YCF54; ChlP, DVR1; POR
ChlH Biobrick correctionAttempt to make ChlH (BBa_K1080001) using combination of gblocks and PCR products, as designed by Macquarie_Australia 2013 iGEM team.
Assembly strategy is: G-Block –1 (470bp) + PCR-1 (304bp) + G-Block-2 (499bp) + G-Block-3 (499bp) + PCR-2 (984bp) + G-Block-4 (500bp) + G-Block-5 (481bp) + PCR-3 (673bp)
Extremely faint bands are seen for
Friday: 29/11/13Another attempt to assemble chlD from PCR fragments
- G Block 1
- G Block 4
- G4 + (G5-G6)
- G1 + PCR1
- G2 + (G3 + PCR2)
December 2013
Week 1
Friday: 06/12/13 Digestion & Ligation of ChlM gene of lac promoter into CAM backboneChlM in AMP backbone vector and lac in backbone were digested using iGEM restriction digestion protocol EcoRI and Pst1 restriction enzymes.
Small amount of growth seen on ChlM, lacA & lacB indicating that they were successfully incorporated into the DHS← cells. Sequencing to confirm required
Transformation of Kanamycin Resistant backbone
We need more of the kanamycin biobrick. Transformation of kanamycin backbone into E. coli cells to produce large amounts of KAN backbone for future ligations.
Monday
09/12/13
PCR reaction for ChlH and ChlD
The overall of the aim of the week was to build ChlH fragment and PCR ChlD. Using the standard PCR protocol, G1+H1, G2 (G3+H2), G4 (G5+G6), ChlD (2) and ChlD (3) were run.
January 2014
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sed metus est. Nullam ut enim urna. Sed sit amet bibendum velit. Morbi erat mauris, commodo at mi non, malesuada pharetra tortor. Nunc hendrerit nulla dignissim odio mattis congue. Fusce non magna sem. Vivamus aliquam feugiat leo sed porta. Mauris placerat non eros quis ornare. Proin viverra sodales ullamcorper. Mauris ac turpis eu risus efficitur ultricies id sit amet neque. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Donec bibendum arcu justo, lacinia cursus justo sodales eget. Mauris vitae augue gravida, bibendum metus sit amet, rutrum magna. Fusce sagittis leo iaculis varius interdum. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.
February 2014
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sed metus est. Nullam ut enim urna. Sed sit amet bibendum velit. Morbi erat mauris, commodo at mi non, malesuada pharetra tortor. Nunc hendrerit nulla dignissim odio mattis congue. Fusce non magna sem. Vivamus aliquam feugiat leo sed porta. Mauris placerat non eros quis ornare. Proin viverra sodales ullamcorper. Mauris ac turpis eu risus efficitur ultricies id sit amet neque. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Donec bibendum arcu justo, lacinia cursus justo sodales eget. Mauris vitae augue gravida, bibendum metus sit amet, rutrum magna. Fusce sagittis leo iaculis varius interdum. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.
August 2014 - Week 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sed metus est. Nullam ut enim urna. Sed sit amet bibendum velit. Morbi erat mauris, commodo at mi non, malesuada pharetra tortor. Nunc hendrerit nulla dignissim odio mattis congue. Fusce non magna sem. Vivamus aliquam feugiat leo sed porta. Mauris placerat non eros quis ornare. Proin viverra sodales ullamcorper. Mauris ac turpis eu risus efficitur ultricies id sit amet neque. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Donec bibendum arcu justo, lacinia cursus justo sodales eget. Mauris vitae augue gravida, bibendum metus sit amet, rutrum magna. Fusce sagittis leo iaculis varius interdum. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.